Search research articles
Contact Us
Filters
Showing results (31-40 of 96) with videos related to
Page
of 10
Sort By:
The Oncologist
|
January 11, 2018
Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study
Patrizia Mondello, Normann Steiner, Wolfgang Willenbacher, et al.
International Emergency Nursing
|
November 20, 2024
What is the optimal outcome for evaluating the triage Systems? Insights from a prospective observational study
Arian Zaboli, Francesco Brigo, Serena Sibilio, et al.
Experimental Hematology & Oncology
|
January 8, 2016
Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent
Patrizia Mondello, Vincenzo Pitini, Valeria Barresi, et al.
European Urology
|
May 27, 2008
Comparison of complications in three incontinent urinary diversions
Armin Pycha, Evi Comploj, Thomas Martini, et al.
The Oncologist
|
July 7, 2016
Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
Patrizia Mondello, Normann Steiner, Wolfgang Willenbacher, et al.
European Urology
|
June 1, 2005
Four years experience in bladder preserving management for muscle invasive bladder cancer
Michele Lodde, Salvatore Palermo, Evi Comploj, et al.
The Prostate
|
March 17, 2006
Molecular biological analysis of the heterogeneous prostate cancer group Gleason score 7
Christine Mian, Michele Lodde, Evi Comploj, et al.
International Emergency Nursing
|
June 27, 2024
Enhancing triage accuracy: The influence of nursing education on risk prediction
Arian Zaboli, Serena Sibilio, Magdalena Massar, et al.
Internal and Emergency Medicine
|
June 20, 2024
Assessing the utility of frailty scores in triage: a comparative study of validated scales
Arian Zaboli, Francesco Brigo, Serena Sibilio, et al.
Anticancer Research
|
September 12, 2013
Docetaxel in the treatment of non-small cell lung cancer (NSCLC) -- an observational study focusing on symptom improvement
Andreas Pircher, Ines Kristin Wasle, Michael Mian, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 96) with videos related to
Sort By:
Page
of 10
The Oncologist
|
January 11, 2018
Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study
Patrizia Mondello, Normann Steiner, Wolfgang Willenbacher, et al.
International Emergency Nursing
|
November 20, 2024
What is the optimal outcome for evaluating the triage Systems? Insights from a prospective observational study
Arian Zaboli, Francesco Brigo, Serena Sibilio, et al.
Experimental Hematology & Oncology
|
January 8, 2016
Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: an aggressive and primary refractory disease responding to an immunomodulatory agent
Patrizia Mondello, Vincenzo Pitini, Valeria Barresi, et al.
European Urology
|
May 27, 2008
Comparison of complications in three incontinent urinary diversions
Armin Pycha, Evi Comploj, Thomas Martini, et al.
The Oncologist
|
July 7, 2016
Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
Patrizia Mondello, Normann Steiner, Wolfgang Willenbacher, et al.
European Urology
|
June 1, 2005
Four years experience in bladder preserving management for muscle invasive bladder cancer
Michele Lodde, Salvatore Palermo, Evi Comploj, et al.
The Prostate
|
March 17, 2006
Molecular biological analysis of the heterogeneous prostate cancer group Gleason score 7
Christine Mian, Michele Lodde, Evi Comploj, et al.
International Emergency Nursing
|
June 27, 2024
Enhancing triage accuracy: The influence of nursing education on risk prediction
Arian Zaboli, Serena Sibilio, Magdalena Massar, et al.
Internal and Emergency Medicine
|
June 20, 2024
Assessing the utility of frailty scores in triage: a comparative study of validated scales
Arian Zaboli, Francesco Brigo, Serena Sibilio, et al.
Anticancer Research
|
September 12, 2013
Docetaxel in the treatment of non-small cell lung cancer (NSCLC) -- an observational study focusing on symptom improvement
Andreas Pircher, Ines Kristin Wasle, Michael Mian, et al.
Page
of 10